AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 23 June 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00146-08v1
52/9/3180    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Labbé, A.-C.
Right arrow Articles by Pépin, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labbé, A.-C.
Right arrow Articles by Pépin, J.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00146-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Clostridium difficile infections (CDI) in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain

Annie-Claude Labbé*, Louise Poirier, Duncan MacCannell, Thomas Louie, Michel Savoie, Claire Béliveau, Michel Laverdière, and Jacques Pépin

Department of Microbiology, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada; Department of Microbiology and Immunology, University of Montreal, Québec, Canada; Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada; Department of Pharmacy, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada; University of Sherbrooke, Québec, Canada

* To whom correspondence should be addressed. Email: ac.labbe{at}umontreal.ca.


   Abstract

Since 2002, an epidemic of Clostridium difficile infections (CDI) has occurred in southern Quebec. At Hôpital Maisonneuve-Rosemont, Montreal, CDI incidence increased from 11/1000 admissions (1999-2002) to 27/1000 admissions (2003-2005). We compared exposures and outcomes of patients infected with different ribopattern strains isolated before (n=55) and during (n=175) the epidemic, as well as in vitro activities of antibiotics against those isolates. During the pre-epidemic period, 46 isolates (84%) were of ribotype 001, 1 of ribotype 027, and 8 of other ribopattern types. In the epidemic period, ribotype 027 strains accounted for 140 (80%) isolates; 26 (15%) were of ribotype 001 and 7 of other ribopattern types. Ribotype 027 strains were highly resistant to fluoroquinolones (FQ) but susceptible to clindamycin. A pattern of prior specific antibiotic exposure selecting for antibiotic-resistant ribotype C. difficile infection was observed for FQ (ribotype 027) and clindamycin (ribotype 001). Mortality was higher in older patients, those with a high Charlson co-morbidity index and those with longer previous hospitalization. In multivariate analysis, patients infected with ribotype 027 were twice as likely to die within 30 days of diagnosis than patients with other ribotypes (AOR: 2.06 95%CI: 1.00-4.22). The observations in this study support the notion that continued selective antibiotic pressure resulted in the superimposition of the hypertoxigenic ribotype 027 clone on top of the prior dominant ribotype 001 clone in a setting of pre-existing high endemicity, thus leading to the high rates of morbidity and mortality seen in the Quebec outbreak. Stringent antibiotic stewardship measures, combined with aggressive infection control are required to curtail the CDI epidemic.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.